1. Вейн А.М., Вознесенская Т.Г., Голубев В.Л., Дюкова Г.М. Депрессия в неврологической практике изд. 3. М.: МИА, 2007.
2. Дамулин И.В., Яхно Н.Н. Гериатрические аспекты заболеваний нервной системы. В кн.: Болезни нервной системы. Под ред. Яхно Н.Н., Штульмана Д.Р. М.: Медицина, 2001; т. 2 (гл. 28): 432–55.
3. Концевой В.А., Медведев А.В., Яковлева О.Б. Депрессия и старение. В кн.: Депрессии и коморбидные расстройства. М., 1997; 114–22.
4. Мосолов С.Н. Клиническое применение современных антидепрессантов. СПб.: МИА, 1995.
5. Смулевич А.Б. Депрессии в общемедицинской практике. М., 2000.
6. Смулевич А.Б., Сыркин А.Л. Психокардиология. М.: МИА, 2005.
7. Alexopulos GS, Meyers BS, Young RS et al. The course of geriatric depression with «reversible dementia»: a controlled study. Am J Psychiat 1993; 150: 1693–9.
8. Alexopulos GS. New concepts for prevention and treatment of late-life depression Am J Psychiat 2001; 158: 835–8.
9. Alexopoulos GS, Bruce ML, Silbersweig D et al. Vascular depression: a new view of late-onset depression. Dialogues in clinical neuroscience. Depres Elderly 1999; 1 (2): 68–80.
10. Alexopulos GS. Depression in the elderly. Lancet 2005; 365: 1961–70.
11. Bondy B. Pathophysiology of depression. Dialog Clin Neuroscience 2002; 4 (1): 7–20.
12. Bremner JD, Narayan M, Anderson ER. Hippocampal volume reduction in major depression. Am J Psychiat 2000; 157: 115–8.
13. Bremner JD, Vythilingam M, Vermetten E et al. Reduced volume of orbitofrontal cjrtex in major depression. Biol Psychiat 2002; 51: 73–279.
14. Cotter D, Mackay D, Landau S et al. Reduced glial cell density and neuronal size in anterior cingulate cortex in major depressive disorder. Arch Gen Psychiat 2001; 58: 545–53.
15. Cummings JL, Mendes MF. Dementia. A clinical approach. Third Ed BH 2003; 12: 477–502.
16. Fuller RW. Serotonin uptake inhibitor... Progr Drug Res 1995; 45: 167–204.
17. Jorm AF. Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 2000; 46 (4): 219–27.
18. Kasper S. Neuroplasticity and the Treatment of Depression. Neuropsychiat Dis Treat 2006; 2 (S2): 14–20.
19. Kasper S, McEwen. Neurobiological and Clinical Effects of the Antidepressant Tianeptine. CNS Drugs 2008; 22 (1): 15–26.
20. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiat 1997; 154: 497–501.
21. Kanner AM. Depression in neurological disorders. Lundbec Inst 2005; 161.
22. Lebowitz BD. Depression in late life in Dialogues in clinical neuroscience. Depres Elderly 1999; 1 (2): 57–65.
23. Lavretsky H, Kumar A. Depressive disorders and cerebrovascular disease in Vascular disease and affective disorders Ed by Chiu E. Ames D.Katona C. Martin Dunitz 2002; 9: 127–43.
24. Lee HB, Lyketsos CG. Depression in AD: heterogeneity and related issues. Biolog Psychiat 2003; 54 (Issue. 3): 353–62.
25. McEwen BS. Structural plasticity of the adult brain… in Dialogues in clinical neuroscience. Neuroplasticity 2004; 6 (2): 119–35.
26. McEwen BS. Mood disorder and allostatic load. Biol Psychiat 2003; 54: 200–7.
27. O Brien J, Perry R, Barber R et al. The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms. Ann NY Acad Sci 2000; 903: 482–9.
28. Robinson RG. Poststroke depression. Prevalence, diognosis, treatment. Biol Psychiat 2003; 54: 376–87.
29. Rosenberg PB, Lyketsos CG. Depression and brain dysfunction. Ed by Gilliam FG, Kanner AM, Sheline YI. 2006; 10: 239–62.
30. Schneider Lon S. Treatment of depressoion in late life. Am J Geriatr Psychiat 1996; 4 (suppl. 1): S51–65.
31. Sapolsky RM. Stress and cognition in The cognitive neurosciences III Ed. M.S.Gazzaniga. 2004; 74: 1031–9.
32. Shakesby AC et al. Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. J Neurosci 2002; 22: 3638–44.
33. ShelineYI, Wang PW, Gado MN et al. Hippocfmpal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93 (9): 3908–13.
34. Sheline YI, Gado MH, Price JL. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 1998; 9 (9): 2023–8.
35. Sheline YI, Sanghavi M, Mintun MA et al. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999; 19 (12): 5054–43.
36. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiat 2003; 160 (8): 1516–8.
37. Stahl SM. Essential Psychopharmacology of depression and Bipolar disorder. Cambridge university press, 2000.
38. Taylor WD, Steffens DC, Krishnan KRR. Vascular depression: a new subtype of depressive disorders. In: Vascular Disease and Affective disorders Ed.by E.Chiu,D D.Ames, C.Katona, Martin Dunitz. 2002; 149–60.
39. Teng E, Lu PH, Cummings JL. Neuropsychiatric symptoms are associated with progression from MCI to AD. Dement Geriatr Cogn Disord 2007; 24 (4): 253–9.
40. Wade DT, Legh-Smith J, Hewer RA. Depressed mood after stroke, a community study of its frequency. Br J Psychiat 1987; 151: 200–5.
41. Wayne Drevets C. Neuroplasticity in mood disorders in Dialogues in clinical neuroscience. Neuroplasticity 2004; 6 (2): 199–216.

Т.Г.Вознесенская